The potential role of miR-155 in the regulation of K-RAS has been discovered in chronic myeloid leukemia (CML) patients, wherein higher levels of K-RAS and downregulated expression of miR-155 have been observed [155]. The gene discussed is KRAS; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.